Cue Health Inc.

HLTH

US2297901009

Software

Real-time Estimate Cboe BZX Other stock markets 02:11:08 2024-05-17 pm EDT			5-day change	1st Jan Change
0.109 ^USD	-7.39%		-14.90%	-32.49%

May. 14	Cue Health Says It Is Evaluating FDA Warning Letter Over COVID-19 Test	MT
Apr. 24	Cue Health Inc. Announces Chief Financial Officer Changes, Effective as of May 13, 2024	CI

Cue Health Announces Earnings Guidance for the Full Year 2021

November 10, 2021 at 04:03 pm EST

Cue Health announced earnings guidance for the full year 2021. For the full year the company expects full year 2021 revenues in the range of $580.0 million to $590.0 million.

Latest news about Cue Health Inc.

Cue Health Says It Is Evaluating FDA Warning Letter Over COVID-19 Test	May. 14	MT
Cue Health Inc. Announces Chief Financial Officer Changes, Effective as of May 13, 2024	Apr. 24	CI
Cue Health Inc. Receives Response Letter from the U.S. Food and Drug Administration Regarding Its De Novo Request	Apr. 09	CI
Cue Health Inc. Announces Executive Changes	Mar. 20	CI
Cue Health Inc. Announces Chief Executive Officer Changes	Mar. 20	CI
North American Morning Briefing : Inflation -2-	Mar. 15	DJ
BTIG Downgrades Cue Health to Neutral From Buy	Mar. 14	MT
Transcript : Cue Health Inc., Q4 2023 Earnings Call, Mar 13, 2024	Mar. 13
Earnings Flash (HLTH) CUE HEALTH Posts Q4 Revenue $18.8M, vs. Street Est of $17.7M	Mar. 13	MT
Cue Health Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 13	CI
Cue Health Inc. Reports Impairment of Long-Lived Assets for the Fourth Quarter Ended December 31, 2023	Mar. 13	CI
Cue Health Inc. Provides Revenue Guidance for the First Quarter of 2024	Mar. 13	CI
Cue Health Enters into Cooperation Agreement with Tarsadia Investments	Feb. 16	CI
Cue Health Appoints Rishi Reddy to Board of Directors	Feb. 16	CI
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data	Jan. 02	MT
US Equity Futures Set Kick Off 2024 Lower Ahead of Manufacturing PMI, Construction Data	Jan. 02	MT
Cue Health Inc.(NasdaqCM:HLTH) dropped from NASDAQ Biotechnology Index	Dec. 15	CI
Goldman Sachs Trims Price Target on Cue Health to $0.50 From $0.75, Maintains Neutral Rating	Nov. 10	MT
Cue Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Transcript : Cue Health Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Earnings Flash (HLTH) CUE HEALTH Reports Q3 Revenue $17.5M, vs. Street Est of $11.2M	Nov. 08	MT
Cue Health Inc. Provides Revenue Guidance for the Fourth Quarter of 2023	Nov. 08	CI
Kelly Day Sends Letter to the Board of Directors of Cue Health	23-10-06	CI
Cue Health Inc. Declares Dividend Distribution	23-09-22	CI
Cue Health Inc.(NasdaqGS:HLTH) dropped from S&P Global BMI Index	23-09-18	CI

Cue Health Inc. is a healthcare technology company. The Company is engaged in providing individuals with a connected diagnostic platform that bridges the physical and virtual care continuum. Its platform, Cue Integrated Care Platform, which consists of hardware, software and diagnostic components: the Cue Health Monitoring System, which is made up of a portable, durable and reusable reader, or Cue Reader, a single-use test cartridge, or Cue Cartridge, and a sample collection wand, or Cue Wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its app and Cue Enterprise Dashboard, and its Cue Ecosystem Integrations and apps, which allow for integrations with third party applications and sensors. Its products include Cue Reader, COVID-19 Test, Cue Test Kits, Cue Care, and Cue+ Membership. It offers solutions for home/personal, business, public sector, healthcare, retail pharmacies, entertainment and education sectors.

Sector

Software

Calendar

2024-08-06 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Cue Health Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.1177 USD

Average target price

0.75 USD

Spread / Average Target

+537.21%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
CUE HEALTH INC.	-32.49%	18.73M
MICROSOFT CORPORATION	+11.55%	3,129B
SYNOPSYS INC.	+9.87%	86.84B
CADENCE DESIGN SYSTEMS, INC.	+6.34%	78.63B
DASSAULT SYSTÈMES SE	-14.66%	53.93B
PALANTIR TECHNOLOGIES INC.	+26.44%	48.21B
ATLASSIAN CORPORATION	-23.86%	47.43B
THE TRADE DESK, INC.	+31.70%	45.58B
SEA LIMITED	+82.74%	41.03B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-8.44%	24.92B

Other Software

Cue Health Inc.

Equities

HLTH

US2297901009

Software

Cue Health Announces Earnings Guidance for the Full Year 2021

Latest news about Cue Health Inc.

Chart Cue Health Inc.

Company Profile

Income Statement Evolution

Ratings for Cue Health Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Software